JESSICA MENNELLA: Open Payments
NPI 1043676471 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 44 payments from 14 companies in 2025. Trend: 2023 $786 · 2024 $848 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $239 |
| Vifor Pharma, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102 |
| PFIZER INC. | 4 | $99 |
| SCPHARMACEUTICALS INC. | 4 | $93 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| BridgeBio Pharma, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| United Therapeutics Corporation | 2 | $47 |
Products named: FARXIGA, Veltassa, Kerendia, JARDIANCE, VYNDAQEL, WAINUA, FUROSCIX, Attruby.
Industry payments across NY — which companies pay providers there.
